RT Journal Article
SR Electronic
T1 SARS-CoV-2 infection in fully vaccinated individuals of old age strongly boosters the humoral immune response
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.19.21260563
DO 10.1101/2021.07.19.21260563
A1 Müller, Lisa
A1 Andrée, Marcel
A1 Ostermann, Philipp Niklas
A1 Jazmati, Nathalie
A1 Flüh, Greta
A1 Fischer, Johannes
A1 Bölke, Edwin
A1 Wisplinghoff, Hilmar
A1 Schaal, Heiner
A1 Drexler, Ingo
A1 Walker, Andreas
A1 Adams, Ortwin
A1 Timm, Jörg
YR 2021
UL http://medrxiv.org/content/early/2021/07/19/2021.07.19.21260563.abstract
AB Introduction Prophylactic vaccination against SARS-CoV-2 is one of the most important measures to contain the COVID-19 pandemic. Recently, break-through infections following vaccination against this virus have been reported. Here, we describe the humoral immune response of break-through infections in fully vaccinated individuals of old age from an outbreak in a nursery home.Methods In cooperation with the local health authority, blood samples from fully vaccinated and infected as well as fully vaccinated and uninfected residents of the nursery home were collected four weeks after the onset of the outbreak. The humoral immune response was determined in a neutralisation assay with replication-competent virus isolates and by a quantitative ELISA.Results In this outbreak a total of 23 residents and four health care workers were tested positive for SARS-CoV-2. Four residents were unvaccinated, including one with a severe course of disease who later deceased. Despite their old age, all vaccinated residents showed no or only mild disease. Comparison of the humoral immune response revealed significantly higher antibody levels in fully vaccinated infected individuals compared to fully vaccinated uninfected individuals (p<0.001). Notably, although only a minority of the vaccinated uninfected group showed neutralisation capacity against SARS-CoV-2, all vaccinated and infected individuals showed high-titer neutralisation of SARS-CoV-2 including the alpha and beta variant.Discussion Large SARS-CoV-2 outbreaks can occur in fully vaccinated populations, but seem to associate with mild disease. SARS-CoV-2 infection in fully vaccinated individuals is a strong booster of the humoral immune response providing enhanced neutralisation capacity against immune evasion variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the VIRus ALliance NRW (VIRAL) from the Ministry of Culture and Science of the State of North Rhine Westphalia (323-8.03-151826) and the Jürgen Manchot Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The retrospective analysis of the outbreak was approved by the ethics committee of the Medical Faculty of the Heinrich-Heine University Dusseldorf, (study no. 2021-1481)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable